Search Results - "MCCAFFREY, Kathryn R"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
  2. 2

    National Responses to HIV Versus HCV-Infection from Virally Contaminated Blood Products among Persons with Hemophilia (PWH): More Different Than Alike by Bennett, Charles L., Frohlich, Lauren E., McCaffrey, Kathryn R., McKoy, June M., Ramsey, Glenn E., Lindenberg, Julia S.

    Published in Blood (16-11-2005)
    “…Background: 95% of HIV- and HCV-infections among PWHs occurred with use of contaminated blood products prior to 1985. Overall, 20% to 90% of PWHs in developed…”
    Get full text
    Journal Article
  3. 3

    2005 Update on Accelerated FDA Approval of Drugs Used To Treat Hematologic Malignancies from the Research on Adverse Drug-Events and Reports (RADAR): Rate of Regular Approval Conversion Remains Low by Bennett, Charles L., Zagory, Jessica A., McKoy, June M., McCaffrey, Kathryn R., Lyons, E. Allison, Belknap, Steven

    Published in Blood (16-11-2005)
    “…Background: At ASH 2004 we reported that prior to 2004, eight drugs had received accelerated approval (AA) for ten hematologic oncology indications, only one…”
    Get full text
    Journal Article
  4. 4

    Incident TTP: Plasmapheresis Therapy-Related Complications Are Common by Zakarija, Anaadriana, McCaffrey, Kathryn R., Bandarenko, Nicholas, Pandey, Dilip, Cursio, John, Tevar, Amul, Kwaan, Hau, Yarnold, Paul R., Burton, Maddie, Bennett, Charles L.

    Published in Blood (16-11-2005)
    “…Background: Plasmapheresis is the mainstay of therapy for thrombotic thrombocytopenic purpura (TTP). Due to the significant mortality associated with TTP if…”
    Get full text
    Journal Article
  5. 5

    Developing National Estimates of the Out-of-Pocket Costs of Cancer: The Importance of Including Patients with Lymphoma by McCaffrey, Kathryn R., Carson, Kenneth R., Kutikova, Lucie, Fisher, Matt, Pickard, Simon, Schumock, Glen, Bowman, Lee, Bennett, Charles L.

    Published in Blood (16-11-2004)
    “…Background: While Congress has mandated that the NIH provide a national estimate of the cost of cancer, almost all cancer cost studies have focused exclusively…”
    Get full text
    Journal Article
  6. 6